Oscar Health Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oscar Health in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Oscar Health stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OSCR, but not buy additional shares or sell existing shares.
View analyst ratings for Oscar Health or view top-rated stocks.

6 brokerages have issued 12 month price objectives for Oscar Health's stock. Their OSCR stock forecasts range from $4.50 to $15.00. On average, they predict Oscar Health's share price to reach $9.50 in the next year. This suggests a possible upside of 94.7% from the stock's current price.
View analysts' price targets for Oscar Health or view top-rated stocks among Wall Street analysts.

Oscar Health's stock was trading at $7.85 at the beginning of the year. Since then, OSCR shares have decreased by 37.8% and is now trading at $4.88.
View the best growth stocks for 2022 here.

Oscar Health is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Oscar Health.

Oscar Health, Inc. (NYSE:OSCR) issued its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.36) earnings per share for the quarter, topping the consensus estimate of ($0.40) by $0.04. Oscar Health had a negative trailing twelve-month return on equity of 37.23% and a negative net margin of 22.93%. During the same quarter in the previous year, the business posted ($0.98) earnings per share.
View Oscar Health's earnings history.

207 employees have rated Oscar Health CEO Mario T. Schlosser on Glassdoor.com. Mario T. Schlosser has an approval rating of 95% among Oscar Health's employees. This puts Mario T. Schlosser in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 70.0% of employees surveyed would recommend working at Oscar Health to a friend.

Some companies that are related to Oscar Health include UnitedHealth Group (UNH), Elevance Health (ELV), Cigna (CI), Humana (HUM), Centene (CNC), Molina Healthcare (MOH), Trupanion (TRUP), Alignment Healthcare (ALHC), Bright Health Group (BHG) and Clover Health Investments (CLOV).
View all of OSCR's competitors.

(OSCR) raised $1 billion in an IPO on Wednesday, March 3rd 2021. The company issued 31,000,000 shares at $32.00-$34.00 per share. Goldman Sachs, Morgan Stanley, Allen & Co., Wells Fargo Securities, BofA Securities and Credit Suisse acted as the underwriters for the IPO and Cowen, Lion Tree, Ramirez & Co. and Siebert Williams Shank were co-managers.

Oscar Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "OSCR."

Shares of OSCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of OSCR stock can currently be purchased for approximately $4.88.

Oscar Health (NYSE:OSCR) has a market capitalization of $1.03 billion and generates $1.84 billion in revenue each year. The company earns $-572,610,000.00 in net income (profit) each year or ($2.68) on an earnings per share basis.

Oscar Health employs 2,621 workers across the globe.

Oscar Health's mailing address is 75 Varick Street 5th Floor, New York NY, 10013. The official website for Oscar Health is www.hioscar.com. The company can be reached via phone at 646-403-3677 or via email at ir@hioscar.com.